Abstract
Low reward responsiveness (RR) is associated with poor psychological well-being, psychiatric disorder risk, and psychotropic treatment resistance. Functional MRI studies have reported decreased activity within the brain’s reward network in individuals with RR deficits, however the neurochemistry underlying network hypofunction in those with low RR remains unclear. This study employed ultra-high field glutamate chemical exchange saturation transfer (GluCEST) imaging to investigate the hypothesis that glutamatergic deficits within the reward network contribute to low RR. GluCEST images were acquired at 7.0 T from 45 participants (ages 15–29, 30 females) including 15 healthy individuals, 11 with depression, and 19 with psychosis spectrum symptoms. The GluCEST contrast, a measure sensitive to local glutamate concentration, was quantified in a meta-analytically defined reward network comprised of cortical, subcortical, and brainstem regions. Associations between brain GluCEST contrast and Behavioral Activation System Scale RR scores were assessed using multiple linear regressions. Analyses revealed that reward network GluCEST contrast was positively and selectively associated with RR, but not other clinical features. Follow-up investigations identified that this association was driven by the subcortical reward network and network areas that encode the salience of valenced stimuli. We observed no association between RR and the GluCEST contrast within non-reward cortex. This study thus provides new evidence that reward network glutamate levels contribute to individual differences in RR. Decreased reward network excitatory neurotransmission or metabolism may be mechanisms driving reward network hypofunction and RR deficits. These findings provide a framework for understanding the efficacy of glutamate-modulating psychotropics such as ketamine for treating anhedonia.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Code availability
All analytic code is available at https://github.com/PennLINC/sydnor_glucest_rewardresponsiveness_2020.
References
McMakin DL, Olino TM, Porta G, Dietz LJ, Emslie G, Clarke G, et al. Anhedonia predicts poorer recovery among youth with selective serotonin reuptake inhibitor treatment–resistant depression. J Am Acad Child Adolesc Psychiatry. 2012;51:404–11.
Uher R, Perlis RH, Henigsberg N, Zobel A, Rietschel M, Mors O, et al. Depression symptom dimensions as predictors of antidepressant treatment outcome: replicable evidence for interest-activity symptoms. Psychol Med. 2012;42:967–80.
Nutt D, Demyttenaere K, Janka Z, Aarre T, Bourin M, Canonico PL, et al. The other face of depression, reduced positive affect: the role of catecholamines in causation and cure. J Psychopharmacol 2007;21:461–71.
Wolf DH. Anhedonia in schizophrenia. Curr Psychiatry Rep. 2006;8:322–8.
Vrieze E, Demyttenaere K, Bruffaerts R, Hermans D, Pizzagalli DA, Sienaert P, et al. Dimensions in major depressive disorder and their relevance for treatment outcome. J Affect Disord. 2014;155:35–41.
Winer ES, Bryant J, Bartoszek G, Rojas E, Nadorff MR, Kilgore J. Mapping the relationship between anxiety, anhedonia, and depression. J Affect Disord. 2017;221:289–96.
Cressman VL, Schobel SA, Steinfeld S, Ben-David S, Thompson JL, Small SA, et al. Anhedonia in the psychosis risk syndrome: associations with social impairment and basal orbitofrontal cortical activity. NPJ Schizophr. 2015;1:15020.
Pizzagalli DA. Depression, stress, and anhedonia: toward a synthesis and integrated model. Annu Rev Clin Psychol. 2014;10:393–423.
Taubitz LE, Pedersen WS, Larson CL. BAS reward responsiveness: a unique predictor of positive psychological functioning. Personal Individ Differ. 2015;80:107–12.
Keller J, Young CB, Kelley E, Prater K, Levitin DJ, Menon V. Trait anhedonia is associated with reduced reactivity and connectivity of mesolimbic and paralimbic reward pathways. J Psychiatr Res. 2013;47:1319–28.
Wacker J, Dillon DG, Pizzagalli DA. The role of the nucleus accumbens and rostral anterior cingulate cortex in anhedonia: integration of resting EEG, fMRI, and volumetric techniques. NeuroImage. 2009;46:327–37.
Simon JJ, Walther S, Fiebach CJ, Friederich H-C, Stippich C, Weisbrod M, et al. Neural reward processing is modulated by approach- and avoidance-related personality traits. NeuroImage. 2010;49:1868–74.
Harvey P-O, Armony J, Malla A, Lepage M. Functional neural substrates of self-reported physical anhedonia in non-clinical individuals and in patients with schizophrenia. J Psychiatr Res. 2010;44:707–16.
Stepien M, Manoliu A, Kubli R, Schneider K, Tobler PN, Seifritz E, et al. Investigating the association of ventral and dorsal striatal dysfunction during reward anticipation with negative symptoms in patients with schizophrenia and healthy individuals. PLOS ONE. 2018;13:e0198215.
Smoski MJ, Felder J, Bizzell J, Green SR, Ernst M, Lynch TR, et al. fMRI of alterations in reward selection, anticipation, and feedback in major depressive disorder. J Affect Disord. 2009;118:69–78.
Sharma A, Wolf DH, Ciric R, Kable JW, Moore TM, Vandekar SN, et al. Common dimensional reward deficits across mood and psychotic disorders: a connectome-wide association study. Am J Psychiatry. 2017;174:657–66.
Haber SN, Knutson B. The reward circuit: linking primate anatomy and human imaging. Neuropsychopharmacology. 2010;35:4–26.
Haber SN. Corticostriatal circuitry. Dialogues Clin Neurosci. 2016;18:7–21.
Sesack SR, Carr DB, Omelchenko N, Pinto A. Anatomical substrates for glutamate-dopamine interactions: evidence for specificity of connections and extrasynaptic actions. Ann N Y Acad Sci. 2003;1003:36–52.
Sesack SR, Grace AA. Cortico-basal ganglia reward network: microcircuitry. Neuropsychopharmacology. 2010;35:27–47.
Höflich A, Michenthaler P, Kasper S, Lanzenberger R. Circuit mechanisms of reward, anhedonia, and depression. Int J Neuropsychopharmacol. 2018;22:105–18.
Geisler S, Wise RA. Functional implications of glutamatergic projections to the ventral tegmental area. Rev Neurosci. 2008;19:227–44.
Stuber GD, Britt JP, Bonci A. Optogenetic modulation of neural circuits that underlie reward seeking. Biol Psychiatry. 2012;71:1061–7.
Cox J, Witten IB. Striatal circuits for reward learning and decision-making. Nat Rev Neurosci. 2019;20:482–94.
D’Souza MS. Glutamatergic transmission in drug reward: implications for drug addiction. Front Neurosci. 2015;9:404.
Bisaga A, Danysz W, Foltin RW. Antagonism of glutamatergic NMDA and mGluR5 receptors decreases consumption of food in baboon model of binge-eating disorder. Eur Neuropsychopharmacol. 2008;18:794–802.
You Z-B, Wang B, Zitzman D, Azari S, Wise RA. A role for conditioned ventral tegmental glutamate release in cocaine seeking. J Neurosci. 2007;27:10546–55.
Lee B, Platt DM, Rowlett JK, Adewale AS, Spealman RD. Attenuation of behavioral effects of cocaine by the metabotropic glutamate receptor 5 antagonist 2-methyl-6-(phenylethynyl)-pyridine in squirrel monkeys: comparison with dizocilpine. J Pharm Exp Ther. 2005;312:1232–40.
Koike H, Iijima M, Chaki S. Involvement of AMPA receptor in both the rapid and sustained antidepressant-like effects of ketamine in animal models of depression. Behav Brain Res. 2011;224:107–11.
Duman RS, Sanacora G, Krystal JH. Altered connectivity in depression: GABA and glutamate neurotransmitter deficits and reversal by novel treatments. Neuron. 2019;102:75–90.
Lally N, Nugent AC, Luckenbaugh DA, Niciu MJ, Roiser JP, Zarate CA. Neural correlates of change in major depressive disorder anhedonia following open-label ketamine. J Psychopharmacol. 2015;29:596–607.
Ballard ED, Wills K, Lally N, Richards EM, Luckenbaugh DA, Walls T, et al. Anhedonia as a clinical correlate of suicidal thoughts in clinical ketamine trials. J Affect Disord. 2017;218:195–200.
Henning A. Proton and multinuclear magnetic resonance spectroscopy in the human brain at ultra-high field strength: a review. NeuroImage. 2018;168:181–98.
Wu B, Warnock G, Zaiss M, Lin C, Chen M, Zhou Z, et al. An overview of CEST MRI for non-MR physicists. EJNMMI Phys. 2016;3:19.
Hu J, Yang S, Xuan Y, Jiang Q, Yang Y, Haacke EM. Simultaneous detection of resolved glutamate, glutamine, and γ-aminobutyric acid at 4 Tesla. J Magn Reson. 2007;185:204–13.
Cai K, Haris M, Singh A, Kogan F, Greenberg JH, Hariharan H, et al. Magnetic resonance imaging of glutamate. Nat Med. 2012;18:302–6.
Nanga RPR, DeBrosse C, Kumar D, Roalf D, McGeehan B, D’Aquilla K, et al. Reproducibility of 2D GluCEST in healthy human volunteers at 7 T. Magn Reson Med. 2018;80:2033–9.
Carver CS, White TL. Behavioral inhibition, behavioral activation, and affective responses to impending reward and punishment: the BIS/BAS Scales. J Pers Soc Psychol. 1994;67:319–33.
Jorm AF, Christensen H, Henderson AS, Jacomb PA, Korten AE, Rodgers B. Using the BIS/BAS scales to measure behavioural inhibition and behavioural activation: factor structure, validity and norms in a large community sample. Personal Individ Differ. 1998;26:49–58.
Campbell-Sills L, Liverant GI, Brown TA. Psychometric evaluation of the behavioral inhibition/behavioral activation scales in a large sample of outpatients with anxiety and mood disorders. Psychol Assess. 2004;16:244–54.
Kasch KL, Rottenberg J, Arnow BA, Gotlib IH. Behavioral activation and inhibition systems and the severity and course of depression. J Abnorm Psychol. 2002;111:589–97.
Kobayashi H, Nemoto T, Koshikawa H, Osono Y, Yamazawa R, Murakami M, et al. A self-reported instrument for prodromal symptoms of psychosis: testing the clinical validity of the PRIME screen-revised (PS-R) in a Japanese population. Schizophr Res. 2008;106:356–62.
Miller T, Cicchetti D, Markovich P, McGlashan T, Woods S. The SIPS screen: a brief self-report screen to detect the schizophrenia prodrome. Schizophr Res. 2004;70:78.
Roalf DR, Nanga RPR, Rupert PE, Hariharan H, Quarmley M, Calkins ME, et al. Glutamate imaging (GluCEST) reveals lower brain GluCEST contrast in patients on the psychosis spectrum. Mol Psychiatry. 2017;22:1298–305.
Marques JP, Kober T, Krueger G, van der Zwaag W, Van de Moortele P-F, Gruetter R. MP2RAGE, a self bias-field corrected sequence for improved segmentation and T1-mapping at high field. NeuroImage. 2010;49:1271–81.
Tustison NJ, Avants BB, Cook PA, Zheng Y, Egan A, Yushkevich PA, et al. N4ITK: improved N3 bias correction. IEEE Trans Med Imaging. 2010;29:1310–20.
Zhang Y, Brady M, Smith S. Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm. IEEE Trans Med Imaging. 2001;20:45–57.
Avants BB, Epstein CL, Grossman M, Gee JC. Symmetric diffeomorphic image registration with cross-correlation: evaluating automated labeling of elderly and neurodegenerative brain. Med Image Anal. 2008;12:26–41.
Bartra O, McGuire JT, Kable JW. The valuation system: a coordinate-based meta-analysis of BOLD fMRI experiments examining neural correlates of subjective value. NeuroImage. 2013;76:412–27.
Desikan RS, Ségonne F, Fischl B, Quinn BT, Dickerson BC, Blacker D, et al. An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. NeuroImage. 2006;31:968–80.
Colic L, von Düring F, Denzel D, Demenescu LR, Lord AR, Martens L, et al. Rostral anterior cingulate glutamine/glutamate disbalance in major depressive disorder depends on symptom severity. Biol Psychiatry Cogn Neurosci Neuroimaging. 2019;4:1049–58.
Walter M, Henning A, Grimm S, Schulte RF, Beck J, Dydak U, et al. The relationship between aberrant neuronal activation in the pregenual anterior cingulate, altered glutamatergic metabolism, and anhedonia in major depression. Arch Gen Psychiatry. 2009;66:478–86.
Gabbay V, Mao X, Klein RG, Ely BA, Babb JS, Panzer AM, et al. Anterior cingulate cortex γ-aminobutyric acid in depressed adolescents. Arch Gen Psychiatry. 2012;69:139–49.
Gabbay V, Bradley KA, Mao X, Ostrover R, Kang G, Shungu DC. Anterior cingulate cortex γ-aminobutyric acid deficits in youth with depression. Transl Psychiatry. 2017;7:e1216.
Sydnor VJ, Roalf DR. A meta-analysis of ultra-high field glutamate, glutamine, GABA and glutathione 1HMRS in psychosis: implications for studies of psychosis risk. Schizophr Res. 2020. https://doi.org/10.1016/j.schres.2020.06.028.
Moriguchi S, Takamiya A, Noda Y, Horita N, Wada M, Tsugawa S, et al. Glutamatergic neurometabolite levels in major depressive disorder: a systematic review and meta-analysis of proton magnetic resonance spectroscopy studies. Mol Psychiatry. 2019;24:952–64.
Godlewska BR, Masaki C, Sharpley AL, Cowen PJ, Emir UE. Brain glutamate in medication-free depressed patients: a proton MRS study at 7 Tesla. Psychol Med. 2018;48:1731–7.
Bradley KA, Alonso CM, Mehra LM, Xu J, Gabbay V. Elevated striatal γ-aminobutyric acid in youth with major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2018;86:203–10.
Moser E, Stahlberg F, Ladd ME, Trattnig S. 7-T MR–from research to clinical applications? NMR Biomed. 2012;25:695–716.
Batten SR, Pomerleau F, Quintero J, Gerhardt GA, Beckmann JS. The role of glutamate signaling in incentive salience: second-by-second glutamate recordings in awake Sprague-Dawley rats. J Neurochem. 2018;145:276–86.
Berridge KC. From prediction error to incentive salience: mesolimbic computation of reward motivation. Eur J Neurosci. 2012;35:1124–43.
Britt JP, Benaliouad F, McDevitt RA, Stuber GD, Wise RA, Bonci A. Synaptic and behavioral profile of multiple glutamatergic inputs to the nucleus accumbens. Neuron. 2012;76:790–803.
Qi J, Zhang S, Wang H-L, Wang H, de Jesus Aceves Buendia J, Hoffman AF, et al. A glutamatergic reward input from the dorsal raphe to ventral tegmental area dopamine neurons. Nat Commun. 2014;5:5390.
Yoo JH, Zell V, Wu J, Punta C, Ramajayam N, Shen X, et al. Activation of pedunculopontine glutamate neurons is reinforcing. J Neurosci. 2017;37:38–46.
Atluri PP, Ryan TA. The kinetics of synaptic vesicle reacidification at hippocampal nerve terminals. J Neurosci. 2006;26:2313–20.
Egashira Y, Takase M, Watanabe S, Ishida J, Fukamizu A, Kaneko R, et al. Unique pH dynamics in GABAergic synaptic vesicles illuminates the mechanism and kinetics of GABA loading. Proc Natl Acad Sci USA. 2016;113:10702–7.
McKenna MC. The glutamate-glutamine cycle is not stoichiometric: Fates of glutamate in brain. J Neurosci Res. 2007;85:3347–58.
Bennik EC, Nederhof E, Ormel J, Oldehinkel AJ. Anhedonia and depressed mood in adolescence: course, stability, and reciprocal relation in the TRAILS study. Eur Child Adolesc Psychiatry. 2014;23:579–86.
Stanton CH, Holmes AJ, Chang SWC, Joormann J. From stress to anhedonia: molecular processes through functional circuits. Trends Neurosci. 2019;42:23–42.
Duman RS. Pathophysiology of depression and innovative treatments: remodeling glutamatergic synaptic connections. Dialogues Clin Neurosci. 2014;16:11–27.
Shimizu M, Suzuki Y, Yamada K, Ueki S, Watanabe M, Igarashi H, et al. Maturational decrease of glutamate in the human cerebral cortex from childhood to young adulthood: a 1H-MR spectroscopy study. Pediatr Res. 2017;82:749–52.
Stringaris A, Vidal-Ribas Belil P, Artiges E, Lemaitre H, Gollier-Briant F, Wolke S, et al. The brain’s response to reward anticipation and depression in adolescence: dimensionality, specificity, and longitudinal predictions in a community-based sample. Am J Psychiatry. 2015;172:1215–23.
Winer ES, Drapeau CW, Veilleux JC, Nadorff MR. The association between anhedonia, suicidal ideation, and suicide attempts in a large student sample. Arch Suicide Res. 2016;20:265–72.
Hawes M, Galynker I, Barzilay S, Yaseen ZS. Anhedonia and suicidal thoughts and behaviors in psychiatric outpatients: the role of acuity. Depress Anxiety. 2018;35:1218–27.
Winer ES, Nadorff MR, Ellis TE, Allen JG, Herrera S, Salem T. Anhedonia predicts suicidal ideation in a large psychiatric inpatient sample. Psychiatry Res. 2014;218:124–8.
Acknowledgements
We would like to thank the recruitment team at the Penn-CHOP Lifespan Brain Institute, led by Thomas Hohing, Karthik Prabhakaran, and Jacqueline Meeks, for assistance with 7.0 T MRI data collection.
Funding
This work was supported by National Institute of Mental Health R01s MH119185 (DRR) and MH120174 (DRR), a National Institute of Aging R56 AG066656 (DRR), a NARSAD Young Investigator Grant from the Brain & Behavior Research Foundation (DRR), a University of Pennsylvania Research Foundation Grant (DRR), and the University of Pennsylvania Institute for Translational Medicine and Therapeutics (TDS, JFY). Additional support was provided by R01 MH119219 (REG, RCG), R01 MH113565 (DHW), R01 MH107703 (TDS), R01 MH112847 (TDS, RTS), T32 MH014654-43 (BL), P41 NIBIB EB015893 (RR), and the Lifespan Brain Institute—a collaboration between the University of Pennsylvania School of Medicine and Children’s Hospital of Philadelphia. The funding sources were not directly involved in study design, data collection, data analysis, data interpretation, or manuscript writing.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
About this article
Cite this article
Sydnor, V.J., Larsen, B., Kohler, C. et al. Diminished reward responsiveness is associated with lower reward network GluCEST: an ultra-high field glutamate imaging study. Mol Psychiatry 26, 2137–2147 (2021). https://doi.org/10.1038/s41380-020-00986-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41380-020-00986-y
This article is cited by
-
Elevating the field for applying neuroimaging to individual patients in psychiatry
Translational Psychiatry (2024)
-
Application of 5T glutamate chemical exchange saturation transfer imaging in brain tumors: preliminary results
Journal of Neuro-Oncology (2024)
-
Neuroimaging of plasticity mechanisms in the human brain: from critical periods to psychiatric conditions
Neuropsychopharmacology (2023)